“Watching Time Tick By…”: Decision Making for Duchenne Muscular Dystrophy Trials

Contemporary Clinical Trials - Netherlands
doi 10.1016/j.cct.2015.11.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Duchenne Muscular Dystrophy

Physiotherapy
Physical TherapySports TherapyRehabilitation
1990English

Duchenne Muscular Dystrophy

English

Duchenne Muscular Dystrophy

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Duchenne Muscular Dystrophy

2020English

Segmental Colonic Transit Time in Duchenne Muscular Dystrophy.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1991English

Emerging Drugs for Duchenne Muscular Dystrophy

Expert Opinion on Emerging Drugs
Pharmacology
2012English

Gene Therapy for Duchenne Muscular Dystrophy

Archives of Neurology
2007English

Steroids in Duchenne Muscular Dystrophy: From Clinical Trials to Genomic Research

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2002English

150. Ex Vivo Gene Therapy of Duchenne Muscular Dystrophy Using iPSCs From Duchenne Muscular Dystrophy Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy